What one share of Myriad Genetics holds
Myriad Genetics is a leading molecular diagnostics and precision medicine company committed to advancing health and well-being for all. We develop and commercialize molecular tests that help patients and providers uncover genetic insights.
Myriad Genetics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $8.61 |
|---|---|
| Profit | −$1.20 |
| Capex (buildings and equipment) | $0.16 |
| Free cash flow | −$0.08 |
| Cash and investments | $1.21 |
| Debt | $1.26 |
| Book value | $3.18 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $3.31 | $0.86 | $0.08 | $0.78 | — | $4.64 |
| 2010 | $3.66 | $1.54 | $0.08 | $1.48 | — | $5.93 |
| 2011 | $4.38 | $1.10 | $0.04 | $1.39 | — | $6.57 |
| 2012 | $5.74 | $1.30 | $0.11 | $1.53 | — | $7.70 |
| 2013 | $7.36 | $1.77 | $0.14 | $1.95 | — | $9.04 |
| 2014 | $9.95 | $2.25 | $0.18 | $2.25 | — | $9.78 |
| 2015 | $9.71 | $1.07 | $0.32 | $1.57 | — | $9.60 |
| 2016 | $10.27 | $1.60 | $0.07 | $2.20 | — | $10.70 |
| 2017 | $11.21 | $0.25 | $0.09 | $1.45 | — | $11.23 |
| 2018 | $10.33 | $1.85 | $0.12 | $1.49 | — | $13.68 |
| 2019 | $11.20 | $0.06 | $0.11 | $0.99 | — | $14.81 |
| 2020 | $8.59 | −$2.69 | $0.14 | $0.68 | — | $12.29 |
| 2020 | $7.45 | −$2.99 | — | — | — | $11.68 |
| 2021 | $8.85 | −$0.35 | $0.23 | $0.01 | — | $12.10 |
| 2022 | $8.42 | −$1.39 | $0.56 | −$1.88 | — | $10.91 |
| 2023 | $9.10 | −$3.18 | $0.76 | −$2.10 | — | $8.71 |
| 2024 | $9.24 | −$1.41 | $0.21 | −$0.31 | — | $7.68 |
| 2025 | $8.90 | −$3.95 | $0.17 | −$0.15 | — | $3.94 |
Common questions about Myriad Genetics
How much does one share of Myriad Genetics earn?
Over the last 12 months, Myriad Genetics lost $1.20 for each share on $8.61 of sales.
Does Myriad Genetics pay a dividend?
Myriad Genetics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Myriad Genetics’s book value per share?
Myriad Genetics’s book value is $3.18 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Myriad Genetics have?
Each share of Myriad Genetics has $1.21 of cash and investments and $1.26 of debt, as of June 30, 2026.
What is Myriad Genetics’s free cash flow per share?
−$0.08 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Myriad Genetics bought back shares?
Myriad Genetics’s share count fell about 6% from 2009 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.